spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Planus, E.
Right arrow Articles by Wang, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Planus, E.
Right arrow Articles by Wang, N.
Ben-Ze'ev, A. G., Robinson, S., Bucher, N. L. and Farmer, S. L (1988). Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary cultures of rat hepatocytes. Proc. Nat. Acad. Sci. USA 85, 1-6.[Abstract/Free Full Text]

Bissell, M. J., Hall, H. G and Parry, G (1982). How does extracellular matrix direct gene expression?. J. Theor. Biol 99, 31-68.[Medline]

Bohuslav, J., Horejsi, V., Hansmanm, C., Stockl, J., Weidle, U. H., Majdic, O., Bartke, I., Knapp, W. and Stockinger H (1995). Urokinase plasminogen activator receptor,2-integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med 181, 1381-1390.[Abstract/Free Full Text]

Cubellis, M. V., Wun, T.-C. and Blasi, F (1990). Receptor mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9, 1079-1085.[Medline]

Dano, K., Andreasen, P. A., Grondahl-Hansen, G., Kristensen, P., Nielsen, L. S. and Skriver, L (1985). Plasminogen activators, tissue degradation and cancer. Advan. Cancer Res 91, 139-266.

Gumbiner, B. M (1996). Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84, 345-357.[Medline]

Gyetko, M. R., Todd, R. F., III, Wilkinson, C. C. and Sitrin, R. G (1994). The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest 93, 1380-1387.

Gyetko, M. R., Sitrin, R. G., Fuller, J. A., Todd, R. F., III, Petty, H. and Standiford, T. J (1995). Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J. Leuk. Biol 58, 533-538.[Abstract]

Hebert, C. A. and Baker, J. B (1988). Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin. J. Cell Biol 106, 1241-1247.[Abstract/Free Full Text]

Ingber, D. E. and Folkman, J (1989). Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J. Cell Biol 109, 317-330.[Abstract/Free Full Text]

Ingber, D. E (1990). Fibronectin controls capillary endothelial cell growth by modulating cell shape. Proc. Nat. Acad. Sci. USA 87, 3579-3583.[Abstract/Free Full Text]

Ingber, D. E., Dike, L. Hansen, L., Karp, S., Liley, H., Maniotis, A., McNamee, H., Mooney, D., Plopper, G., Sims, J. and Wang, N (1994). Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int. Rev. Cytol 150, 173-224.[Medline]

Jacobson, K., Sheets, E. D. and Simson, R (1995). Revisiting the fluid mosaic model of membranes. Science 268, 1441-1442.[Free Full Text]

Lauffenburger, D. A. and Horwitz, A. F (1996). Cell migration: a physically integrated molecular process. Cell 84, 359-369.[Medline]

Lawrence, D. A., Olsen, S. T., Palaniappamn, S. and Ginsberg, D (1994). Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. J. Biol. Chem 269, 27657-27662.[Abstract/Free Full Text]

Liotta, L. A (1992). Cancer cell invasion and metastasis. Sci. Am 266, 54-59.[Medline]

Liu, G., Shuman, M. A. and Cohen, R. L (1994). Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int. J. Cancer 60, 501-506.

Mimuro, J., Muramatsu, S., Kurano, Y., Uchida, Y., Ikadai, H., Watanabe, S. and Sakata, Y (1993). Identification of the plasminogen activator inhibitor-binding heptapeptide in vitronectin. Biochemistry 32, 2314-2320.[Medline]

Mooney, D., Hansen, L., Farmer, S., Vacanti, J. and Ingber, D (1992). Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J. Cell. Physiol 151, 497-505.[Medline]

Myohanen, H. T., Stephens, R. W., Hedman, K., Tapiovaara, H., Ronne, E., Hoyer-Hansen, G., Dano, K. and Vaheri, A (1993). Distribution and lateral mobility of the urokinase receptor complex at the cell surface. J. Histochem. Cytochem 41, 1291-1301.[Abstract]

Nusrat, A. R. and Chapman, H. A (1991). An autocrine role for urokinase inphobol ester-mediated differentiation of myeloid cell lines. J. Clin. Invest 87, 1091-1097.

Opas, M (1989). Expression of the differentiated phenotype by epithelial cells is regulated by both biochemistry and mechanics of substratum. Dev. Biol 131, 281-293.[Medline]

Pepper, M. S. and Montesano, M (1992). Proteolytic balance and capillary morphogenesis. Cell Diff. Dev 32, 319-328.

Pepper, M. S., Sappino, A.-P., Stocklin, R., Montesano, R., Orci, L. and Vassalli, J.-D (1993). Upregulation of urokinase receptor expression on migrating endothelial cells. J. Cell Biol 122, 673-684.[Abstract/Free Full Text]

Plopper, G. and Ingber, D. E (1993). Rapid induction and isolation of focal adhesion complexes. Biochem. Biophys. Res. Commun 193, 571-578.[Medline]

Plopper, G., McNamee, H., Dike, L., Bojanowski, K. and Ingber, D. E (1995). Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell 6, 1349-1365.[Abstract]

Ploug, M., Ronne, E., Behrendt, N., Jensen, A. L., Blasi, F. and Dano, K (1991). Cellular receptor for urokinase plasminogen activator. J. Biol. Chem 266, 1926-1933.[Abstract/Free Full Text]

Pollanen, J., Saksela, O., Salonen, E.-M., Andreasen, P., Nielsen, L., Dano, K. and Vaheri, A (1987). Distinct localization of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J. Cell Biol 104, 1085-1096.[Abstract/Free Full Text]

Quax, P. H. A., Frisdal, E., Pedersen, N., Bonavaud, S., Thibert, P., Martelly, I., Verheijen, J., Blasi, F. and Barlovatz-Meimon, G (1992). Modulation of activities and RNA of the level of components of the plasminogen activation during differentiation of human myogenic satellite cells in vitro. Dev. Biol 151, 166-175.[Medline]

Reilly, T. M., Mousa, S. A., Seetharam, R. and Racanelli, A. L (1994). Recombinant plasminogen activator inhibitor type 1: a review of structural, functional, and biological aspects. Blood Coag. Fibrinol 5, 73-81.[Medline]

Schwartz, M. A. and Ingber, D. E (1994). Integrating with integrins. Mol. Biol. Cell 5, 389-393.[Abstract]

Seiffert, D. and Loskutoff, D. J (1991). Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin. J. Biol. Chem 266, 2824-2830.[Abstract/Free Full Text]

Sheetz, M (1994). Cell migration by graded attachment to substrates and contraction. Semin. Cell Biol 5, 149-155.[Medline]

Shetty, S., Kumar, A., Jonson, A., Pueblitz, S. and Idell, S (1995). Urokinase receptor in human malignant mesothelioma cells, role in tumor cell mitogenesis and proteolysis. Am. J. Physiol 268, 972-982.

Sigurdardottir, O. and Wiman, B (1994). Identification of a PAI-1 binding site in vitronectin. Biochim. Biophys. Acta 1208, 104-110.[Medline]

Stefansson, S. and Lawrence, D. A (1996). The serpin PAI-1 inhibits cell migration by blocking integrinv 3 binding to vitronectin. Nature 383, 441-443.[Medline]

Sumiyoshi, K., Baba, S., Sakagushi, S., Urano, T., Takada, Y. and Takada, A (1991). Increase in levels of plasminogen activator and type 1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb. Res 63, 59-71.[Medline]

Van Meijer, M., Gebbink, R. K., Preissner, K. T. and Pannekoek, H (1994). Determination of the vitronectin binding site on plasminogen activator inhibitor 1 (PAI-1). FEBS Lett 352, 342-346.[Medline]

Vassalli, J.-D., Sappino, A.-P. and Belin, D (1991). The plasminogen activator/plasmin system. J. Clin. Invest 88, 1067-1072.

Waltz, D. A., Sailor, L. Z. and Chapman, H. A (1993). Cytokines induce urokinase-dependent adhesion of human myeloid cells. J. Clin. Invest 91, 1541-1552.

Wang, N., Butler, J. P. and Ingber, D. E (1993). Mechanotransduction across the cell surface and through the cytoskeleton. Science 260, 1124-1127.[Abstract/Free Full Text]

Wei, Y., Waltz, D. A., Rao, N., Drummond, R. J., Rosenberg, S. and Chapman, H. A (1994). Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem 269, 32380-32388.[Abstract/Free Full Text]

Wei, Y., Lukashev, M., Simon, D. I., Bodary S. C., Rosenberg, S., Doyle M. V. and Chapman H. A (1996). Regulation of integrin function by the urokinase receptor. Science 273, 1551-1555.[Abstract]

Williams, E. J., Furness, J., Walsh, F. S. and Doherty, P (1994). Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM and N cadherin. Neuron 3, 583-594.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Arciniegas, M. G. Frid, I. S. Douglas, and K. R. Stenmark
Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L1 - L8.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Maquerlot, S. Galiacy, M. Malo, C. Guignabert, D. A. Lawrence, M.-P. d'Ortho, and G. Barlovatz-Meimon
Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing
Am. J. Pathol., November 1, 2006; 169(5): 1624 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S.-H. Kwak, S. Mitra, K. Bdeir, D. Strassheim, J. S. Park, J. Y. Kim, S. Idell, D. Cines, and E. Abraham
The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins
J. Leukoc. Biol., October 1, 2005; 78(4): 937 - 945.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. Puig-de-Morales, E. Millet, B. Fabry, D. Navajas, N. Wang, J. P. Butler, and J. J. Fredberg
Cytoskeletal mechanics in adherent human airway smooth muscle cells: probe specificity and scaling of protein-protein dynamics
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C643 - C654.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
M. L. Wahl, T. L. Moser, and S. V. Pizzo
Angiostatin and Anti-angiogenic Therapy in Human Disease
Recent Prog. Horm. Res., January 1, 2004; 59(1): 73 - 104.
[Abstract] [Full Text]

Home page
 J. Appl. Physiol.Home page
A. E. Barani, A.-C. Durieux, O. Sabido, and D. Freyssenet
Age-related changes in the mitotic and metabolic characteristics of muscle-derived cells
J Appl Physiol, November 1, 2003; 95(5): 2089 - 2098.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Hirashima, H. Kobayashi, M. Suzuki, Y. Tanaka, N. Kanayama, and T. Terao
Transforming Growth Factor-{beta}1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial Cells
J. Biol. Chem., July 11, 2003; 278(29): 26793 - 26802.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Tanaka, H. Koyama, T. Ichii, A. Shioi, M. Hosoi, E. W. Raines, and Y. Nishizawa
Fibrillar Collagen Regulation of Plasminogen Activator Inhibitor-1 Is Involved in Altered Smooth Muscle Cell Migration
Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1573 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
B. Chazaud, R. Ricoux, C. Christov, A. Plonquet, R. K. Gherardi, and G. Barlovatz-Meimon
Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell Populations
Am. J. Pathol., January 1, 2002; 160(1): 237 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. A. Wickstrom, T. Veikkola, M. Rehn, T. Pihlajaniemi, K. Alitalo, and J. Keski-Oja
Endostatin-induced Modulation of Plasminogen Activation with Concomitant Loss of Focal Adhesions and Actin Stress Fibers in Cultured Human Endothelial Cells
Cancer Res., September 1, 2001; 61(17): 6511 - 6516.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
A J Wilson and P R Gibson
Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro
Gut, July 1, 2000; 47(1): 105 - 111.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Ikari, K. Fujikawa, K. O. Yee, and S. M. Schwartz
alpha 1-Proteinase Inhibitor, alpha 1-Antichymotrypsin, or alpha 2-Macroglobulin Is Required for Vascular Smooth Muscle Cell Spreading in Three-dimensional Fibrin Gel
J. Biol. Chem., April 21, 2000; 275(17): 12799 - 12805.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Montero and Y. Nagamine
Regulation by p38 Mitogen-activated Protein Kinase of Adenylate- and Uridylate-Rich Element-mediated Urokinase-Type Plasminogen Activator (uPA) Messenger RNA Stability and uPA-dependent in Vitro Cell Invasion
Cancer Res., October 1, 1999; 59(20): 5286 - 5293.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Robert, I. Bolon, S. Gazzeri, S. Veyrenc, C. Brambilla, and E. Brambilla
Expression of Plasminogen Activator Inhibitors 1 and 2 in Lung Cancer and Their Role in Tumor Progression
Clin. Cancer Res., August 1, 1999; 5(8): 2094 - 2102.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Liu, J. Yao, I. de Belle, R.-P. Huang, E. Adamson, and D. Mercola
The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-beta 1, Fibronectin, and Plasminogen Activator Inhibitor-1
J. Biol. Chem., February 12, 1999; 274(7): 4400 - 4411.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Summary Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Planus, E.
Right arrow Articles by Wang, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Planus, E.
Right arrow Articles by Wang, N.